Nikolai Strusberg, MD, discussed how proton therapy and thyroid dose affect clinical hypothyroidism risk after supraclavicular breast radiation.
|Poll|September 1, 2011
Mammary Gland Biopsy of 38-Year-Old Patient
Author(s)Robert D. Cardiff, MD, PhD
Advertisement
A 38-year-old female (para 3, gravida 3), complains of persistent bilateral mammary gland pain associated with a "lumpy" feeling when she does a self-examination. She carries a family history of breast cancer in both her mother and older sister. A biopsy revealed the following image.
The most likely diagnosis is:
Advertisement
Related to this article
Ralph V. Boccia, MD, FACP, compared MRD data with Tec-Dara and Tal-Dara and explained how sustained MRD negativity is reshaping myeloma care.
Alexandra Dreyfuss, MD, MS, weighs bridging vs consolidative radiotherapy strategies around CAR T-cell infusion in myeloma.
In a phase 1 trial of patients with platinum-sensitive high-grade ovarian cancer, a personalized neoantigen vaccine plus nivolumab caused no unexpected safety signals.
The new guidelines include 10 recommendations spanning extended molecular testing, JAK inhibitor use, anemia management, and other areas in myelofibrosis.
Erik Bengtsen, MD, shares a key depression screening question and explains when oncologists can start a low-dose antidepressant.
Heath Skinner, MD, PhD, discussed the 4 focus areas of the 2026 Radiation Oncology Conference and what it takes to implement new radiation service lines.
The FDA has assigned a Prescription Drug User Fee Act date of March 31, 2027, for tabelecleucel in this indication.
Advertisement
Advertisement
Trending on CancerNetwork
1
VS-7375 Yields Responses in KRAS G12D–Mutated Solid Tumors
2
Reading a Changed Eye Examination and Impact on Therapy
3
Personalized Cancer Vaccine Combo Is Feasible in Platinum-Sensitive Ovarian Cancer
4
Proton Therapy Tied to Less Hypothyroidism After Supraclavicular Breast RT
5